Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-17-000003

Options or other derivatives

  • CEO / President acquired 300,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K. · CEO / President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-08 Other acquisition : show line 1 in the form Options to buy Common Stock +300,000 495,833 D
Loading xslF345X03/primary_doc.xml…